CJC-1295 No DAC + Ipamorelin is a research peptide combination featuring two distinct compounds associated with growth hormone regulation. The combination is commonly studied in relation to endogenous growth hormone (GH) secretion, endocrine signaling, and the GH/IGF-1 axis.
It is generally characterized as a modified growth hormone-releasing hormone (GHRH) analogue without the Drug Affinity Complex (DAC) modification associated with longer-acting CJC-1295 formulations.
Research involving GHRH analogues such as CJC-1295 focuses on GHRH receptor activity, pituitary GH secretion, endocrine signaling, and downstream IGF-1 pathways.
Ipamorelin is a synthetic pentapeptide growth hormone secretagogue that primarily interacts with the growth hormone secretagogue receptor (GHS-R), also known as the ghrelin receptor.
Research has investigated Ipamorelin in relation to GH secretion, GHS-R signaling, endocrine regulation, GH/IGF-1 pathways, and metabolic research.
How the Combination Is Studied
The two peptides are of interest because they are associated with different signaling pathways involved in GH regulation:
CJC-1295 No DAC → GHRH receptor signaling → GH secretion
Ipamorelin → GHS-R/ghrelin receptor signaling → GH secretion
This makes the combination relevant to experimental research investigating interactions between GHRH-mediated and growth-hormone-secretagogue pathways.
Potential Research Benefits
Growth Hormone Research
The combination can be investigated in laboratory research examining endogenous GH secretion and regulation.
GH/IGF-1 Signaling
Researchers can study downstream signaling CJC-1295 No DAC + Ipamorelin associated with growth hormone and IGF-1 pathways.
GHRH Receptor Research
CJC-1295 No DAC provides a model for investigating GHRH-related receptor signaling and pituitary GH regulation.
Ghrelin Receptor Research
Ipamorelin provides a research model for studying GHS-R/ghrelin receptor activity and growth-hormone secretagogue pathways.
Endocrine Research
The combination is relevant to research into hypothalamic-pituitary regulation and endocrine signaling.
Peptide Signaling Research
Using two peptides associated with separate GH-regulatory pathways allows researchers to investigate peptide-receptor interactions and endocrine mechanisms.
Metabolic Research
The GH/IGF-1 system has relationships with broader metabolic processes, making this combination relevant to experimental metabolic research.
Key Research Areas
Growth hormone research
GH secretion
GH/IGF-1 signaling
GHRH research
GHRH receptor signaling
Growth hormone secretagogue research
GHS-R research
Ghrelin receptor research
Endocrine research
Pituitary research
Hormone signaling
Peptide-receptor research
Metabolic research
Growth hormone regulation
Peptide research